BSE Live
Dec 11, 12:32Prev. Close
345.20
Open Price
343.55
Bid Price (Qty.)
344.90 (28)
Offer Price (Qty.)
346.10 (24)
NSE Live
Dec 11, 12:32Prev. Close
343.25
Open Price
341.10
Bid Price (Qty.)
345.20 (2)
Offer Price (Qty.)
345.75 (12)
| Cash Flow of Gufic Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 69.93 | 86.14 | 79.70 | 95.84 | 44.23 | |
| Net CashFlow From Operating Activities | 122.78 | -7.46 | -26.59 | 104.44 | 89.06 | |
| Net Cash Used In Investing Activities | -71.79 | -102.40 | -190.73 | -95.94 | -8.51 | |
| Net Cash Used From Financing Activities | -37.20 | 82.38 | 234.31 | -3.10 | -78.62 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 13.78 | -27.48 | 16.99 | 5.41 | 1.94 | |
| Cash And Cash Equivalents Begin of Year | 1.13 | 28.60 | 11.61 | 6.20 | 4.26 | |
| Cash And Cash Equivalents End Of Year | 14.91 | 1.13 | 28.60 | 11.61 | 6.20 |
04.12.2025
Gufic Bio Consolidated September 2025 Net Sales at Rs 237.05 crore, up 16.1% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y
04.12.2025
Gufic Bio Consolidated September 2025 Net Sales at Rs 237.05 crore, up 16.1% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y